Epidemiology of cholangiocarcinoma

Best Practice and Research: Clinical Gastroenterology

Volumn 29, Issue 2, 2015, Pages 221-232

  Bergquist, Annika ^a   Von Seth, Erik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biliary cytology; Cholangiocarcinoma; Epidemiology; Primary sclerosing cholangitis; Risk factors

Indexed keywords

CA 19-9 ANTIGEN;

ARTICLE; BILE DUCT CARCINOMA; CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; LIVER DISEASE; LIVER TRANSPLANTATION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASITOSIS; PRIMARY SCLEROSING CHOLANGITIS; TREATMENT OUTCOME; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; COMPLICATION; HEPATIC DUCT; HUMAN; INCIDENCE; INTRAHEPATIC BILE DUCT; PATHOLOGY; RISK FACTOR; SCLEROSING CHOLANGITIS;

BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; HUMANS; INCIDENCE; RISK FACTORS;

EID: 84929288947     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2015.02.003     Document Type: Review

References (82)

1. S. Rizvi, and G.J. Gores Pathogenesis, diagnosis, and management of cholangiocarcinoma Gastroenterology 145 6 2013 Dec 1215 1229 PubMed PMID: 24140396. Pubmed Central PMCID: PMC3862291. Epub 2013/10/22. eng
2. J.E. Everhart, and C.E. Ruhl Burden of digestive diseases in the United States part III: liver, biliary tract, and pancreas Gastroenterology 136 4 2009 Apr 1134 1144 PubMed PMID: 19245868. Epub 2009/02/28. eng
3. Y.H. Shaib, J.A. Davila, L. Henderson, K.A. McGlynn, and H.B. El-Serag Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the United States: a population-based study J Clin Gastroenterol 41 10 2007 Nov-Dec 911 917 PubMed PMID: 18090160. Epub 2007/12/20. eng
4. Y. Ustundag, and Y. Bayraktar Cholangiocarcinoma: a compact review of the literature World J Gastroenterol 14 42 2008 Nov 14 6458 6466 PubMed PMID: 19030196. Pubmed Central PMCID: PMC2773330. Epub 2008/11/26. eng
5. S.A. Khan, B.R. Davidson, R.D. Goldin, N. Heaton, J. Karani, and S.P. Pereira et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update Gut 61 12 2012 Dec 1657 1669 PubMed PMID: 22895392. Epub 2012/08/17. eng
6. International classification of diseases for oncology: ICD-O 2000 WHO Geneva
7. A. Nakeeb, H.A. Pitt, T.A. Sohn, J. Coleman, R.A. Abrams, and S. Piantadosi et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors Ann Surg 224 4 1996 Oct 463 473 discussion 73-5. PubMed PMID: 8857851. Pubmed Central PMCID: PMC1235406. Epub 1996/10/01. eng
8. M.L. DeOliveira, S.C. Cunningham, J.L. Cameron, F. Kamangar, J.M. Winter, and K.D. Lillemoe et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution Ann Surg 245 5 2007 May 755 762 PubMed PMID: 17457168. Pubmed Central PMCID: PMC1877058. Epub 2007/04/26. eng
9. G.L. Tyson, and H.B. El-Serag Risk factors for cholangiocarcinoma Hepatol (Baltimore, Md) 54 1 2011 Jul 173 184 PubMed PMID: 21488076. Pubmed Central PMCID: PMC3125451. Epub 2011/04/14. eng
10. S. Sriamporn, P. Pisani, V. Pipitgool, K. Suwanrungruang, S. Kamsa-ard, and D.M. Parkin Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand Trop Med Int Health 9 5 2004 May 588 594 PubMed PMID: 15117303. Epub 2004/05/01. eng
11. V. Vatanasapt, N. Martin, H. Sriplung, K. Chindavijak, S. Sontipong, and H. Sriamporn et al. Cancer incidence in Thailand, 1988-1991 Cancer Epidemiol Biomarkers Prev 4 5 1995 Jul-Aug 475 483 PubMed PMID: 7549802. Epub 1995/07/01. eng
12. B. Sripa, and C. Pairojkul Cholangiocarcinoma: lessons from Thailand Curr Opin Gastroenterol 24 3 2008 May 349 356 PubMed PMID: 18408464. Pubmed Central PMCID: PMC4130346. Epub 2008/04/15. eng
13. S. Mosconi, G.D. Beretta, R. Labianca, M.G. Zampino, G. Gatta, and V. Heinemann Cholangiocarcinoma Crit Rev Oncol Hematol 69 3 2009 Mar 259 270 PubMed PMID: 18977670
14. T.M. Welzel, K.A. McGlynn, A.W. Hsing, T.R. O'Brien, and R.M. Pfeiffer Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States J Natl Cancer Inst 98 12 2006 Jun 21 873 875 PubMed PMID: 16788161. Epub 2006/06/22. eng
15. S.A. Khan, S. Emadossadaty, N.G. Ladep, H.C. Thomas, P. Elliott, and S.D. Taylor-Robinson et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol 56 4 2012 848 854
16. C. de Martel, M. Plummer, and S. Franceschi Cholangiocarcinoma: descriptive epidemiology and risk factors Gastroenterol Clin Biol 34 3 2010 Mar 173 180 PubMed PMID: 20202771. Epub 2010/03/06. eng
17. T. Patel Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States Hepatol (Baltimore, Md) 33 6 2001 Jun 1353 1357 PubMed PMID: 11391522. eng
18. S.D. Taylor-Robinson, M.B. Toledano, S. Arora, T.J. Keegan, S. Hargreaves, and A. Beck et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998 Gut 48 6 2001 Jun 816 820 PubMed PMID: 11358902. Pubmed Central PMCID: 1728314. eng
19. S.A. Khan, S.D. Taylor-Robinson, M.B. Toledano, A. Beck, P. Elliott, and H.C. Thomas Changing international trends in mortality rates for liver, biliary and pancreatic tumours J Hepatol 37 6 2002 Dec 806 813 PubMed PMID: 12445422. eng
20. T. Patel Worldwide trends in mortality from biliary tract malignancies BMC Cancer 2 2002 May 3 (1471-2407 (Electronic)):10. PubMed PMID: 11991810. Pubmed Central PMCID: 113759. eng
21. Y.H. Shaib, J.A. Davila, K. McGlynn, and H.B. El-Serag Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 40 3 2004 Mar 472 477 PubMed PMID: 15123362. Epub 2004/05/05. eng
22. D. Alvaro, E. Crocetti, S. Ferretti, M.C. Bragazzi, and R. Capocaccia Descriptive epidemiology of cholangiocarcinoma in Italy Dig Liver Dis 42 7 2010 Jul 490 495 PubMed PMID: 20022823. Epub 2009/12/22. eng
23. T. von Hahn, S. Ciesek, G. Wegener, R.R. Plentz, T.J. Weismuller, and H. Wedemeyer et al. Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany Scand J Gastroenterol 46 9 2011 Sep 1092 1098 PubMed PMID: 21692710. Epub 2011/06/23. eng
24. M. Utada, Y. Ohno, T. Tamaki, T. Sobue, and G. Endo Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan J Epidemiol 24 3 2014 193 199 PubMed PMID: 24614916. Pubmed Central PMCID: PMC4000766. Epub 2014/03/13. eng
25. P. Jepsen, H. Vilstrup, R.E. Tarone, S. Friis, and H.T. Sorensen Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002 J Natl Cancer Inst 99 11 2007 Jun 6 895 897 PubMed PMID: 17551150. Epub 2007/06/07. eng
26. C. Lepage, V. Cottet, M. Chauvenet, J.M. Phelip, L. Bedenne, and J. Faivre et al. Trends in the incidence and management of biliary tract cancer: a French population-based study J Hepatol 54 2 2011 Feb 306 310 PubMed PMID: 21056501. Epub 2010/11/09. eng
27. G.L. Tyson, J.A. Ilyas, Z. Duan, L.K. Green, M. Younes, and H.B. El-Serag et al. Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification Dig Dis Sci. 59 12 2014 Dec 3103 3110 PubMed PMID: 25204668. Eng
28. N. Kaewpitoon, S.J. Kaewpitoon, and P. Pengsaa Opisthorchiasis in Thailand: review and current status World J Gastroenterol 14 15 2008 Apr 21 2297 2302 PubMed PMID: 18416453. Pubmed Central PMCID: PMC2705081. Epub 2008/04/18. eng
29. P. Sithithaworn, P. Yongvanit, K. Duenngai, N. Kiatsopit, and C. Pairojkul Roles of liver fluke infection as risk factor for cholangiocarcinoma J Hepatobiliary Pancreatic Sci 21 5 2014 May 301 308 PubMed PMID: 24408775. Epub 2014/01/11. eng
30. H.R. Shin, J.K. Oh, E. Masuyer, M.P. Curado, V. Bouvard, and Y.Y. Fang et al. Epidemiology of cholangiocarcinoma: an update focusing on risk factors Cancer Sci 101 3 2010 Mar 579 585 PubMed PMID: 20085587. eng
31. J.Y. Mabrut, G. Bozio, C. Hubert, and J.F. Gigot Management of congenital bile duct cysts Dig Surg 27 1 2010 12 18 PubMed PMID: 20357446
32. K. Soreide, H. Korner, J. Havnen, and J.A. Soreide Bile duct cysts in adults Br J Surg 91 12 2004 Dec 1538 1548 PubMed PMID: 15549778
33. K. Chijiiwa, H. Yamashita, J. Yoshida, S. Kuroki, and M. Tanaka Current management and long-term prognosis of hepatolithiasis Arch Surg 130 2 1995 Feb 194 197 PubMed PMID: 7848091. Epub 1995/02/01. eng
34. J.Y. Lee, J.S. Kim, J.M. Moon, S.A. Lim, W. Chung, and E.H. Lim et al. Incidence of cholangiocarcinoma with or without previous resection of liver for hepatolithiasis Gut Liver 7 4 2013 Jul 475 479 PubMed PMID: 23898390. Pubmed Central PMCID: PMC3724038. Epub 2013/07/31. eng
35. C.H. Su, W.Y. Lui, and F.K. P'Eng Relative prevalence of gallstone diseases in Taiwan. A nationwide cooperative study Dig Dis Sci 37 5 1992 May 764 768 PubMed PMID: 1563321. Epub 1992/05/01. eng
36. S. Tazuma Gallstone disease: epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic) Best Pract Res Clin Gastroenterol 20 6 2006 1075 1083 PubMed PMID: 17127189. Epub 2006/11/28. eng
37. H. Nordenstedt, F. Mattsson, H. El-Serag, and J. Lagergren Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma Br J Cancer 106 5 2012 Feb 28 1011 1015 PubMed PMID: 22240785. Pubmed Central PMCID: PMC3305961. Epub 2012/01/14. eng
38. Y.H. Shaib, H.B. El-Serag, J.A. Davila, R. Morgan, and K.A. McGlynn Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study Gastroenterology 128 3 2005 Mar 620 626 PubMed PMID: 15765398. Epub 2005/03/15. eng
39. T.M. Welzel, B.I. Graubard, H.B. El-Serag, Y.H. Shaib, A.W. Hsing, and J.A. Davila et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study Clin Gastroenterol Hepatol 5 10 2007 Oct 1221 1228 PubMed PMID: 17689296. Pubmed Central PMCID: PMC2083573. Epub 2007/08/11. eng
40. T.M. Welzel, L. Mellemkjaer, G. Gloria, L.C. Sakoda, A.W. Hsing, and L. El Ghormli et al. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study Int J Cancer 120 3 2007 Feb 1 638 641 PubMed PMID: 17109384. Epub 2006/11/17. eng
41. S. Ralphs, and S.A. Khan The role of the hepatitis viruses in cholangiocarcinoma J Viral Hepat 20 5 2013 May 297 305 PubMed PMID: 23565610. eng
42. W.C. Palmer, and T. Patel Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma J Hepatol 57 1 2012 Jul 69 76 PubMed PMID: 22420979. Pubmed Central PMCID: PMC3804834. Epub 2012/03/17. eng
43. Y. Zhou, Y. Zhao, B. Li, J. Huang, L. Wu, and D. Xu et al. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis BMC Cancer 12 2012 289 PubMed PMID: 22799744. Pubmed Central PMCID: PMC3411483. Epub 2012/07/18. eng
44. M. Li, J. Li, P. Li, H. Li, T. Su, and R. Zhu et al. Hepatitis B virus infection increases the risk of cholangiocarcinoma: a meta-analysis and systematic review J Gastroenterol Hepatol 27 10 2012 Oct 1561 1568 PubMed PMID: 22694354. Epub 2012/06/15. eng
45. T.M. Welzel, B.I. Graubard, S. Zeuzem, H.B. El-Serag, J.A. Davila, and K.A. McGlynn Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-medicare database Hepatol (Baltimore, Md) 54 2 2011 Aug 463 471 PubMed PMID: 21538440. Pubmed Central PMCID: PMC4141525. Epub 2011/05/04. eng
46. E. Melum, T.H. Karlsen, E. Schrumpf, A. Bergquist, E. Thorsby, and K.M. Boberg et al. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms Hepatol (Baltimore, Md) 47 1 2008 Jan 90 96 PubMed PMID: 18023027. Epub 2007/11/21. eng
47. R. Erichsen, P. Jepsen, H. Vilstrup, A. Ekbom, and H.T. Sorensen Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978-2003 Eur J Epidemiol 24 9 2009 513 520 PubMed PMID: 19557525. Epub 2009/06/27. eng
48. A. Bergquist, A. Ekbom, R. Olsson, D. Kornfeldt, L. Loof, and A. Danielsson et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis J Hepatol 36 3 2002 Mar 321 327 PubMed PMID: 11867174. Epub 2002/02/28. eng
49. K.M. Boberg, A. Bergquist, S. Mitchell, A. Pares, F. Rosina, and U. Broome et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation Scand J Gastroenterol 37 10 2002 Oct 1205 1211 PubMed PMID: 12408527. Epub 2002/11/01. eng
50. K. Burak, P. Angulo, T.M. Pasha, K. Egan, J. Petz, and K.D. Lindor Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis Am J Gastroenterol 99 3 2004 Mar 523 526 PubMed PMID: 15056096. Epub 2004/04/02. eng
51. J. Fevery, C. Verslype, G. Lai, R. Aerts, and W. Van Steenbergen Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis Dig Dis Sci 52 11 2007 Nov 3123 3135 PubMed PMID: 17431781. Epub 2007/04/14. eng
52. G. Morris-Stiff, C. Bhati, S. Olliff, S. Hubscher, B. Gunson, and D. Mayer et al. Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience Dig Surg 25 2 2008 126 132 PubMed PMID: 18446034. Epub 2008/05/01. eng
53. K. Boonstra, R.K. Weersma, K.J. van Erpecum, E.A. Rauws, B.W. Spanier, and A.C. Poen et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis Hepatol (Baltimore, Md) 58 6 2013 Dec 2045 2055 PubMed PMID: 23775876
54. N. Razumilava, G.J. Gores, and K.D. Lindor Cancer surveillance in patients with primary sclerosing cholangitis Hepatol (Baltimore, Md) 54 5 2011 Nov 1842 1852 PubMed PMID: 21793028. Pubmed Central PMCID: PMC3205332. Epub 2011/07/28. eng
55. S.E. Kerr, E.G. Barr Fritcher, M.B. Campion, J.S. Voss, B.R. Kipp, and K.C. Halling et al. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma Hum Pathol 45 9 2014 Sep 1797 1804 PubMed PMID: 25027853
56. J.T. Lewis, J.A. Talwalkar, C.B. Rosen, T.C. Smyrk, and S.C. Abraham Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma Am J Surg Pathol 34 1 2010 Jan 27 34 PubMed PMID: 19898228. Epub 2009/11/10. eng
57. N. Chalasani, A. Baluyut, A. Ismail, A. Zaman, G. Sood, and R. Ghalib et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study Hepatol (Baltimore, Md) 31 1 2000 Jan 7 11 PubMed PMID: 10613720. Epub 1999/12/29. eng
58. S.A. Ahrendt, H.A. Pitt, A. Nakeeb, A.S. Klein, K.D. Lillemoe, and A.N. Kalloo et al. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis J Gastrointest Surg 3 4 1999 Jul-Aug 357 367 discussion 67-8. PubMed PMID: 10482687. Epub 1999/09/11. eng
59. B. Nashan, H.J. Schlitt, G. Tusch, K.J. Oldhafer, B. Ringe, and S. Wagner et al. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation Hepatol (Baltimore, Md) 23 5 1996 May 1105 1111 PubMed PMID: 8621141. Epub 1996/05/01. eng
60. P. Charatcharoenwitthaya, F.B. Enders, K.C. Halling, and K.D. Lindor Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis Hepatol (Baltimore, Md) 48 4 2008 Oct 1106 1117 PubMed PMID: 18785620
61. P. Sangfelt, A. Sundin, A. Wanders, I. Rasmussen, B.M. Karlson, and A. Bergquist et al. Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET J Hepatol 61 6 2014 Dec 1352 1357 PubMed PMID: 25111173. Epub 2014/08/12. Eng
62. E. Sinakos, A.K. Saenger, J. Keach, W.R. Kim, and K.D. Lindor Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma Clin Gastroenterol Hepatol 9 5 2011 May 434-439.e1. PubMed PMID: 21334457. Epub 2011/02/22. eng
63. C. Levy, J. Lymp, P. Angulo, G.J. Gores, N. Larusso, and K.D. Lindor The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis Dig Dis Sci 50 9 2005 1734 1740
64. G. Trikudanathan, U. Navaneethan, B. Njei, J.J. Vargo, and M.A. Parsi Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis Gastrointest Endosc 79 5 2014 May 783 789 PubMed PMID: 24140129
65. M. Rabinovitz, A.B. Zajko, T. Hassanein, B. Shetty, K.M. Bron, and R.R. Schade et al. Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures Hepatol (Baltimore, Md) 12 4 Pt 1 1990 Oct 747 752 PubMed PMID: 2210678. Epub 1990/10/01. eng
66. U. Navaneethan, B. Njei, P.G. Venkatesh, J.J. Vargo, and M.A. Parsi Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis Gastrointest Endosc 79 6 2014 Jun 943-950.e3. PubMed PMID: 24360654
67. E.G. Barr Fritcher, B.R. Kipp, J.S. Voss, A.C. Clayton, K.D. Lindor, and K.C. Halling et al. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma Am J Gastroenterol 106 11 2011 Nov 2023 2028 PubMed PMID: 21844920
68. E. von Seth, U. Arnelo, L. Enochsson, and A. Bergquist Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography Liver Int Off J Int Assoc Study of the Liver 35 1 2015 Jan 254 262 PubMed PMID: 25041074. Epub 2014/07/22. Eng
69. S. Ismail, L. Kylanpaa, H. Mustonen, J. Halttunen, O. Lindstrom, and K. Jokelainen et al. Risk factors for complications of ERCP in primary sclerosing cholangitis Endoscopy 44 12 2012 Dec 1133 1138 PubMed PMID: 23108808
70. S.Y. Bangarulingam, A.A. Gossard, B.T. Petersen, B.J. Ott, and K.D. Lindor Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis Am J Gastroenterol 104 4 2009 Apr 855 860 PubMed PMID: 19259076. Epub 2009/03/05. eng
71. T.O. Lankisch, J. Metzger, A.A. Negm, K. Vosskuhl, E. Schiffer, and J. Siwy et al. Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis Hepatol (Baltimore, Md) 53 3 2011 Mar 875 884 PubMed PMID: 21374660. Epub 2011/03/05. eng
72. J. Metzger, A.A. Negm, R.R. Plentz, T.J. Weismuller, J. Wedemeyer, and T.H. Karlsen et al. Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders Gut 62 1 2013 Jan 122 130 PubMed PMID: 22580416. Epub 2012/05/15. eng
73. L. Li, D. Masica, M. Ishida, C. Tomuleasa, S. Umegaki, and A.N. Kalloo et al. Human bile contains MicroRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis Hepatol (Baltimore, Md) 60 3 2014 Sep 896 907 PubMed PMID: 24497320. Pubmed Central PMCID: 4121391. Epub 2014/02/06. Eng
74. I.W. Graziadei, R.H. Wiesner, P.J. Marotta, M.K. Porayko, J.E. Hay, and M.R. Charlton et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis Hepatol (Baltimore, Md) 30 5 1999 Nov 1121 1127 PubMed PMID: 10534330. Epub 1999/10/26. eng
75. S. Friman, A. Foss, H. Isoniemi, M. Olausson, K. Hockerstedt, and S. Yamamoto et al. Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results Scand J Gastroenterol 46 3 2011 Mar 370 375 PubMed PMID: 21073376
76. S. Darwish Murad, W.R. Kim, D.M. Harnois, D.D. Douglas, J. Burton, and L.M. Kulik et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers Gastroenterology 143 1 2012 Jul 88-98.e3; quiz e14. PubMed PMID: 22504095. Pubmed Central PMCID: 3846443
77. S. Friman Cholangiocarcinoma-current treatment options Scand J Surg 100 1 2011 30 34 PubMed PMID: 21491796. Epub 2011/04/16. eng
78. European Association for the Study of the L. EASL clinical practice guidelines: management of cholestatic liver diseases J Hepatol 51 2 2009 Aug 237 267 PubMed PMID: 19501929
79. S.Y. Bangarulingam, E. Bjornsson, F. Enders, E.G. Barr Fritcher, G. Gores, and K.C. Halling et al. Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis Hepatol (Baltimore, Md) 51 1 2010 Jan 174 180 PubMed PMID: 19877179
80. R. Chapman, J. Fevery, A. Kalloo, D.M. Nagorney, K.M. Boberg, and B. Shneider et al. Diagnosis and management of primary sclerosing cholangitis Hepatol (Baltimore, Md) 51 2 2010 Feb 660 678 PubMed PMID: 20101749. Epub 2010/01/27. eng
81. B.S. Lee, B.H. Cha, E.C. Park, and J. Roh Risk factors for perihilar cholangiocarcinoma: A hospital-based case-control study Liver Int Off J Int Assoc Study Liver 35 3 2015 Mar 1048 1053 PubMed PMID: 24923595. Epub 2014/06/14. Eng
82. F. Donato, U. Gelatti, A. Tagger, M. Favret, M.L. Ribero, and F. Callea et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy Cancer Causes Control CCC 12 10 2001 Dec 959 964 PubMed PMID: 11808716. Epub 2002/01/26. eng